Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation

Agriculture & Biology

• fatty liver 100%
• atherosclerosis 90%
• inflammation 73%
• aorta 66%
• cholesterol 61%
• Toll-like receptor 4 48%
• liver 47%
• lesions (animal) 39%
• cholesteryl esters 37%
• Toll-like receptor 2 25%
• foam cells 22%
• receptors 21%
• hypercholesterolemia 19%
• fibrosis 19%
• New Zealand White rabbit 19%
• carrageenan 18%
• subcutaneous injection 18%
• wild animals 17%
• hyperplasia 17%
• high fat diet 17%
• intravenous injection 16%
• animal models 14%
• triacylglycerols 12%
• rabbits 10%
• metabolites 10%
• diet 8%

Medicine & Life Sciences

• Non-alcoholic Fatty Liver Disease 86%
• Atherosclerosis 65%
• Cholesterol 59%
• Inflammation 47%
• Aorta 46%
• Liver 34%
• Cholesterol Esters 32%
• Toll-Like Receptor 4 31%
• Rabbits 19%
• Diet 18%
• Toll-Like Receptor 2 17%
• Foam Cells 16%
• Wild Animals 16%
• Carrageenan 15%
• Tunica Intima 14%
• Subcutaneous Injections 14%
• Hypercholesterolemia 13%
• Hyperplasia 11%
• Triglycerides 10%
• Fibrosis 10%
• Animal Models 9%
• Pathology 8%
• Control Groups 7%
• Serum 6%

Chemical Compounds

• Cholesterol 72%
• Cholesteryl Ester 42%
• Carrageenan 20%
• Triglyceride 17%
• Foam 14%
• Marker 14%
• White 13%
• Metabolite 11%